9 drug(s) with this reaction
7,356 total reports
Confusional State has been reported as an adverse reaction across 9 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 7,356 adverse event reports mention confusional state in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with confusional state, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have confusional state listed in their FDA adverse event reports, sorted by report count:
In addition to confusional state, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
9 drug(s) manufactured by Abbvie Inc have confusional state listed in their FDA adverse event reports: LEVOTHYROXINE SODIUM, DIVALPROEX SODIUM, FENOFIBRATE, VENETOCLAX, PANCRELIPASE, and others.
There are a combined 7,356 reports of confusional state across 9 Abbvie Inc drug(s) in the FDA adverse event database.